Cafepharma Today

May 28 2025 - GLP-1 prescriptions for weight loss soar, despite obstacles
GLP-1 prescriptions for weight loss soar, despite obstacles
FDA approves use of Sanofi's meningococcal vaccine in infants
GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win
AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pozen shares take wild ride before FDA decision
bizjournals.com
Saturday, May 1, 2010 - 10:45am
tags:
Pozen, Vimovo, arthritis
Cyclacel Receives Complaint Filed by Celgene Seeking to Avoid Certain Cyclacel Patents
Yahoo/Global NewsWire
Saturday, May 1, 2010 - 10:35am
tags:
Cyclacel, romidepsin, Celgene, T-cell lymphoma
MannKind Corporation Q1 2010 Earnings Call Transcript
Seeking Alpha
Saturday, May 1, 2010 - 10:33am
tags:
MannKind, earnings
Acorda Therapeutics, Inc. Q1 2010 Earnings Call Transcript
Seeking Alpha
Saturday, May 1, 2010 - 10:31am
tags:
Acorda Therapeutics
Dendreon: Yes, It Got FDA Approval, But Here's What It Did Wrong
Seeking Alpha
Saturday, May 1, 2010 - 10:27am
tags:
Dendreon, Provenge
The Next Biotech Drug to Watch: InterMune’s Pirfenidone
Minyanville
Saturday, May 1, 2010 - 10:23am
tags:
InterMune, pirfenidone, idiopathic pulmonary fibrosis
Living the Blockbuster Model
Motley Fool
Friday, April 30, 2010 - 3:49pm
tags:
GSK, AstraZeneca, Sanofi, Eli Lilly
Earnings Preview: Pfizer to report 1Q results
Yahoo/AP
Friday, April 30, 2010 - 3:43pm
tags:
earnings, Pfizer
Pozen shares sink ahead of FDA decision
Marketwatch
Friday, April 30, 2010 - 3:38pm
tags:
vivmo, Pozen, FDA, AstraZeneca
Bristol Myers Still Rocks
Motley Fool
Friday, April 30, 2010 - 3:33pm
tags:
Bristol-Myers Squibb
Appeals Court Upholds Pay-For-Delay Deals
Pharmalot
Friday, April 30, 2010 - 8:59am
tags:
pay-for-delay, FTC
Three Trends That Will Impact Pharma's Future
Seeking Alpha
Friday, April 30, 2010 - 8:58am
tags:
Novartis, Teva Pharmaceuticals, Dr Reddy's, generics, Actavis, emerging markets, personalized medicine
Study sharpens focus on Glaxo's heart drug hope
Reuters
Friday, April 30, 2010 - 8:24am
tags:
GSK, darapladib
Alexion remains takeover target, just not this year
Reuters
Friday, April 30, 2010 - 8:20am
tags:
Alexion, M&A
GSK Notes: We Have More Sales Reps in Emerging Markets than in West
InVivo
Friday, April 30, 2010 - 8:19am
tags:
GSK, emerging markets
FDA may lift hold on Proellex: Repros
Marketwatch
Friday, April 30, 2010 - 7:57am
tags:
FDA, Proellex, Repros Therapeutics
Prostate Cancer Vaccine Provenge Faces Toughest Test Yet: The Real World
BNET Pharma
Friday, April 30, 2010 - 7:50am
tags:
prostate cancer, vaccines, Provenge, Dendreon
Diabetes Death Watch Slipped Into Health Law by Lilly, Novo
Bloomberg
Friday, April 30, 2010 - 7:49am
tags:
diabetes, healthcare reform, Novo Nordisk, Eli Lilly
Ho Hum, J&J Raises Dividend - Why Shares Should Be Bought
Seeking Alpha
Friday, April 30, 2010 - 7:48am
tags:
JNJ, dividends
Mannkind's Afrezza Seems Short of Breath
Seeking Alpha
Friday, April 30, 2010 - 7:47am
tags:
Eli Lilly, Afrezza, MannKind, diabetes, inhaled insulin, Pfizer, Novo Nordisk

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.